Accordingly, loss of Oct1 increases the AMP/ATP ratio, activating the AMP-activated protein kinase and lowering hepatic triglyceride levels in both healthy and leptin-deficient mice, suggesting that OCT1 plays a critical role in thiamine-dependent lipid and glucose metabolism, with implications for metabolic syndrome pathophysiology. The gene discussed is SLC22A1; the disease is metabolic syndrome.